Activest Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Sell
33
-63
-66% -$21.6K ﹤0.01% 546
2026
Q1
$33.8K Buy
+96
New +$34.2K 0.01% 405
2025
Q4
Sell
-50
Closed -$14.1K 1130
2025
Q3
$14.1K Sell
50
-56
-53% -$16.2K ﹤0.01% 429
2025
Q2
$29.6K Hold
106
0.01% 264
2025
Q1
$33K Buy
106
+103
+3,433% +$30.4K 0.01% 227
2024
Q4
$782 Buy
+3
New +$890 ﹤0.01% 482
2022
Q3
Sell
-14
Closed -$3K 442
2022
Q2
$3K Buy
+14
New +$3.43K ﹤0.01% 284

Other funds holding AMGN

Activest Wealth Management's AMGN Position: Q2 2026 in Review

Activest Wealth Management reduced its Amgen (AMGN) stake by 66% in Q2 2026, selling an estimated $21.6K and leaving 33 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Activest Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 7 quarters since. The position peaked at $33.8K in Q1 2026. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Activest Wealth Management held 33 shares of Amgen worth $11.9K as of Q2 2026.
  • Activest Wealth Management sold 63 Amgen shares in Q2 2026, an estimated $21.6K.
  • Amgen made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #546 holding.
  • Activest Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 7 quarters since.
  • Activest Wealth Management's Amgen position peaked at $33.8K in Q1 2026.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.